1. Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 study. Issue 7 (28th May 2020) Authors: Klapdor, Rudiger; Hillemanns, Peter; Wölber, Linn; Jückstock, Julia; Hilpert, Felix; de Gregorio, Nikolaus; Hasenburg, Annette; Sehouli, Jalid; Fürst, Sophie; Strauss, Hans; Baumann, Klaus; Thiel, Falk; Mustea, Alexander; Meier, Werner; Harter, Philipp; Wimberger, Pauline; Hanker, Lars; Schmalfel... Journal: International journal of gynecological cancer Issue: Volume 30:Issue 7(2020) Page Start: 920 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association between obesity and vulvar cancer recurrence: an analysis of the AGO‐CaRE‐1 study. Issue 7 (July 2020) Authors: Klapdor, Rudiger; Hillemanns, Peter; Wölber, Linn; Jückstock, Julia; Hilpert, Felix; de Gregorio, Nikolaus; Hasenburg, Annette; Sehouli, Jalid; Fürst, Sophie; Strauss, Hans; Baumann, Klaus; Thiel, Falk; Mustea, Alexander; Meier, Werner; Harter, Philipp; Wimberger, Pauline; Hanker, Lars; Schmalfel... Journal: International journal of gynecological cancer Issue: Volume 30:Issue 7(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial. Issue 5 (May 2020) Authors: Pfisterer, Jacobus; Shannon, Catherine M; Baumann, Klaus; Rau, Joern; Harter, Philipp; Joly, Florence; Sehouli, Jalid; Canzler, Ulrich; Schmalfeldt, Barbara; Dean, Andrew P; Hein, Alexander; Zeimet, Alain G; Hanker, Lars C; Petit, Thierry; Marmé, Frederik; El-Balat, Ahmed; Glasspool, Rosalind; de... Journal: Lancet oncology Issue: Volume 21:Issue 5(2020) Page Start: 699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial. Issue 5 (May 2020) Authors: Pfisterer, Jacobus; Shannon, Catherine M; Baumann, Klaus; Rau, Joern; Harter, Philipp; Joly, Florence; Sehouli, Jalid; Canzler, Ulrich; Schmalfeldt, Barbara; Dean, Andrew P; Hein, Alexander; Zeimet, Alain G; Hanker, Lars C; Petit, Thierry; Marmé, Frederik; El-Balat, Ahmed; Glasspool, Rosalind; de... Journal: Lancet oncology Issue: Volume 21:Issue 5(2020) Page Start: 699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial. Issue 3 (February 2015) Authors: Mahner, Sven; Meier, Werner; du Bois, Andreas; Brown, Chris; Lorusso, Domenica; Dell'Anna, Tiziana; Cretin, Jacques; Havsteen, Hanne; Bessette, Paul; Zeimet, Alain G.; Vergote, Ignace; Vasey, Paul; Pujade-Lauraine, Eric; Gladieff, Laurence; Ferrero, Annamaria Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: 352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Corrigendum to "Borderline tumours of the ovary: A cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie AGO Study Group" [Eur J Cancer 49 (2013) 1905–1914]. (September 2016) Authors: du Bois, Andreas; Ewald-Riegler, Nina; de Gregorio, Nikolaus; Reuss, Alexander; Mahner, Sven; Fotopoulou, Christina; Kommoss, Friedrich; Schmalfeldt, Barbara; Hilpert, Felix; Fehm, Tanja; Burges, Alexander; Meier, Werner; Hillemanns, Peter; Hanker, Lars; Hasenburg, Annette; Strauss, Hans-Georg; H... Journal: European journal of cancer Issue: Volume 65(2016) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883). Issue 9 (12th April 2019) Authors: Hauke, Jan; Hahnen, Eric; Schneider, Stephanie; Reuss, Alexander; Richters, Lisa; Kommoss, Stefan; Heimbach, André; Marmé, Frederik; Schmidt, Sandra; Prieske, Katharina; Gevensleben, Heidrun; Burges, Alexander; Borde, Julika; De Gregorio, Nikolaus; Nürnberg, Peter; El-Balat, Ahmed; Thiele, Holger... Journal: Journal of medical genetics Issue: Volume 56:Issue 9(2019) Page Start: 574 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy. Issue 9 (30th October 2018) Authors: Friedlander, Michael; Matulonis, Ursula; Gourley, Charlie; du Bois, Andreas; Vergote, Ignace; Rustin, Gordon; Scott, Clare; Meier, Werner; Shapira-Frommer, Ronnie; Safra, Tamar; Matei, Daniela; Shirinkin, Vadim; Selle, Frédéric; Fielding, Anitra; Lowe, Elizabeth; McMurtry, Emma; Spencer, Stuart; ... Journal: British journal of cancer Issue: Volume 119:Issue 9(2018) Page Start: 1075 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Olaparib maintenance therapy in patients with platinum‐sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy. Issue 12 (8th April 2016) Authors: Matulonis, Ursula A.; Harter, Philipp; Gourley, Charlie; Friedlander, Michael; Vergote, Ignace; Rustin, Gordon; Scott, Clare; Meier, Werner; Shapira‐Frommer, Ronnie; Safra, Tamar; Matei, Daniela; Fielding, Anitra; Spencer, Stuart; Parry, David; Grinsted, Lynda; Ledermann, Jonathan A. Journal: Cancer Issue: Volume 122:Issue 12(2016) Page Start: 1844 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial. Issue 4 (1st February 2023) Authors: Pfisterer, Jacobus; Joly, Florence; Kristensen, Gunnar; Rau, Joern; Mahner, Sven; Pautier, Patricia; El-Balat, Ahmed; Kurtz, Jean-Emmanuel; Canzler, Ulrich; Sehouli, Jalid; Heubner, Martin L.; Hartkopf, Andreas D.; Baumann, Klaus; Hasenburg, Annette; Hanker, Lars C.; Belau, Antje; Schmalfeldt, Ba... Journal: Journal of clinical oncology Issue: Volume 41:Issue 4(2023) Page Start: 893 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗